SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.07.20 | Roche overweight | Morgan Stanley | |
| 28.07.20 | Novartis neutral | Morgan Stanley | |
| 27.07.20 | Roche buy | UBS AG | |
| 24.07.20 | Roche overweight | Barclays Capital | |
| 24.07.20 | Roche Neutral | Credit Suisse Group | |
| 24.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.07.20 | Roche buy | UBS AG | |
| 23.07.20 | Roche overweight | JP Morgan Chase & Co. | |
| 23.07.20 | Roche overweight | Barclays Capital | |
| 23.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.07.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.07.20 | Novartis Hold | HSBC | |
| 22.07.20 | Novartis Neutral | Credit Suisse Group | |
| 22.07.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.07.20 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.20 | Novartis Hold | Kepler Cheuvreux | |
| 21.07.20 | Novartis Neutral | UBS AG | |
| 21.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis buy | Jefferies & Company Inc. | |
| 21.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.07.20 | Roche overweight | JP Morgan Chase & Co. | |
| 16.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.20 | Roche Outperform | Bernstein Research | |
| 07.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.07.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.06.20 | Roche overweight | JP Morgan Chase & Co. | |
| 25.06.20 | Roche Neutral | Credit Suisse Group | |
| 25.06.20 | Novartis Neutral | UBS AG | |
| 25.06.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.06.20 | Roche buy | Oddo BHF | |
| 22.06.20 | Novartis buy | Oddo BHF | |
| 19.06.20 | Roche overweight | JP Morgan Chase & Co. | |
| 19.06.20 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 18.06.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.06.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.06.20 | Roche Conviction Buy | Goldman Sachs Group Inc. |